IceCure Medical (ICCM)

• Market cap: $66.8M
• 1 day: -4.07%
• 5 days: -7.09%
• 1 month: 5.36%
• 3 months: 107.49%
• 6 months: 69.37%
• Year to date: -4.07%
• 1 year: -9.92%
• 5 years: -89.17%
• 10 years: -89.17%

About: Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Employees: 64

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

7% more funds holding

Funds holding: 14 [Q2] → 15 (+1) [Q3]

0.37% less ownership

Funds ownership: 0.78% [Q2] → 0.41% (-0.37%) [Q3]

59% less capital invested

Capital invested by funds: $276K [Q2] → $113K (-$164K) [Q3]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $2.50 112% upside
• Avg. target: $2.50 112% upside
• High target: $2.50 112% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Yi Chen 39% 1-year accuracy 61 / 156 met price target

112% upside $2.50

Buy Reiterated

27 Nov 2024